M48U1 and Tenofovir combination synergistically inhibits HIV infection in activated PBMCs and human cervicovaginal histocultures.
about
Influence of Chitosan Swelling Behaviour on Controlled Release of Tenofovir from Mucoadhesive Vaginal Systems for Prevention of Sexual Transmission of HIV.In silico-based screen synergistic drug combinations from herb medicines: a case using Cistanche tubulosa.Increased CD127+ and decreased CD57+ T cell expression levels in HIV-infected patients on NRTI-sparing regimens.
P2860
M48U1 and Tenofovir combination synergistically inhibits HIV infection in activated PBMCs and human cervicovaginal histocultures.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
M48U1 and Tenofovir combinatio ...... cervicovaginal histocultures.
@en
M48U1 and Tenofovir combinatio ...... cervicovaginal histocultures.
@nl
type
label
M48U1 and Tenofovir combinatio ...... cervicovaginal histocultures.
@en
M48U1 and Tenofovir combinatio ...... cervicovaginal histocultures.
@nl
prefLabel
M48U1 and Tenofovir combinatio ...... cervicovaginal histocultures.
@en
M48U1 and Tenofovir combinatio ...... cervicovaginal histocultures.
@nl
P2093
P2860
P50
P356
P1433
P1476
M48U1 and Tenofovir combinatio ...... cervicovaginal histocultures.
@en
P2093
Caterina Signoretto
Claudia Pastori
David Lembo
Davide Gibellini
Erica Diani
Gilles Ponchel
Isabella Bon
Loïc Martin
Lucia Lopalco
Maria Carla Re
P2860
P2888
P356
10.1038/SREP41018
P407
P577
2017-02-01T00:00:00Z
P6179
1083400817